Showing results (1881-1890 of 2,234) with videos related to

Sort By:
Pageof 224
G3 (Bethesda, Md.)|August 17, 2014
Performance of the Cas9 nickase system in Drosophila melanogasterXingjie Ren, Zhihao Yang, Decai Mao, et al.
The Korean Journal of Hepatology|March 28, 2008
[Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients]Jin Hee Cho, Jae Youn Cheong, Joon Koo Kang, et al.
Molecular Ecology|April 22, 2017
Molecular adaptation in the world's deepest-living animal: Insights from transcriptome sequencing of the hadal amphipod Hirondellea gigasYi Lan, Jin Sun, Renmao Tian, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2014
Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signalingSun Wook Cho, Young A Kim, Hyun Jin Sun, et al.
Biomaterials Science|September 27, 2018
Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapyBin Yang, Kaiyuan Wang, Dong Zhang, et al.
Advanced Healthcare Materials|October 3, 2021
Zwitterion-Driven Shape Program of Prodrug Nanoassemblies with High Stability, High Tumor Accumulation, and High Antitumor ActivityGuanting Li, Bingjun Sun, Shunzhe Zheng, et al.
Environmental Research|March 9, 2024
Greenness and its composition and configuration in association with allergic rhinitis in preschool childrenHan Chen, Xia Meng, Yongfu Yu, et al.
European Child & Adolescent Psychiatry|May 17, 2025
Atypical brain function hierarchy in autism spectrum disorder: insights from a novel analytical approach based on neuronal oscillation patternYunge Zhang, Huanjie Li, Wenyu Gu, et al.
Bioactive Materials|February 8, 2021
Erythrocyte membrane-camouflaged carrier-free nanoassembly of FRET photosensitizer pairs with high therapeutic efficiency and high security for programmed cancer synergistic phototherapyXuanbo Zhang, Jianchen Xiong, Kaiyuan Wang, et al.
BMB Reports|April 29, 2025
Erratum to: Celecoxib is the only nonsteroidal anti-inflammatory drug to inhibit bone progression in spondyloarthritisJin Sun Choi, Ji-Young Kim, Min-Joo Ahn, et al.
Pageof 224